Phytase (myo-inositol hexakisphosphate phosphohydrolase) is every type of phosphatase enzyme that catalyzes the hydrolysis of phytic acid. It is an enzyme which breaks down phytate and enhances calcium (Ca), zinc (Zn), sodium (Na), magnesium (Mg) and amino acid availability and digestibility in broilers and pigs. Phytases fall into two main categories:
By type, powder and granular type collectively accounted for more than 60% share of the global market. These two types are also projected to be the fastest growing segment over the next six years. Liquid is another widely used type. It is projected to grow at a CAGR of 5.8% over the next six years in terms of revenue. Huvepharma has developed a new form for enzyme application in the feed mill: water soluble enzymes which are distorted into fluid enzymes for PPLA (Post Pellet Liquid Application), on site at the feed mill. The NSP enzyme Hostazym X and the phytases Hostazym P and OptiPhos are both available as water soluble powders (WSP). Production takes place by a unique method, as the enzymes have to be extremely concentrated and instantly water soluble in icy water. Large product availability at competitive prices and increasing demand in areas where product can be obtained in liquid form easily will open new avenues for liquid animal feed phytase market growth.
The market research study on “Phytase Market (Type: Granular, Liquid, Powder, Thermostable; Application: Pharmaceuticals, Food, Feed) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025” offers a detailed insights on the global phytase market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global phytase market, its type, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global phytase market size and volume, and segment markets by type, application, and geography along with the information on companies operating in the market. The phytase market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America, Middle East & Africa followed by major countries. For each region, the market size and volume for different segments has been covered under the scope of report. The major players profiled in the report include BASF, DuPont, DSM, AB Enzymes, Guangdong VTR Bio-Tech Co., Ltd, Beijing Smistyle, Jinan Tiantianxiang (TTX), and others.
The global phytase market is segmented as below:
Market By Type
Market By Application
Market By Geography
Introduction The global In Vitro Diagnostics is market size is anticipated to around USD 99.0 billion by 2026, this market is anticipated to grow with 7.1% CAGR during the forecast time period. Market Dynamics Increasing occurrence of chronic diseases is foreseen to drive the
Introduction The global minimally invasive surgical instruments is market size is anticipated to around USD 39.0 billion by 2026, this market is anticipated to grow with 10.1% CAGR during the forecast time period. The inclination for Minimally Invasive Surgical (MIS) techniques is increasing as they are less traumatic and they encourage quicker recoup process than
Introduction The global automated liquid handling technology is market size is anticipated to around USD 3.2 billion by 2026, this market is anticipated to grow with 10.1% CAGR during the forecast time period. The market is driven by speedy acceptance of liquid handling robots to substitute conventionally reserved ‘wet lab’ bench work areas is expected
Introduction The global NET treatment is market size is anticipated to around USD 4.2 billion by 2026, this market is anticipated to grow with 10.1% CAGR during the forecast time period. The market is driven by growing occurrence of cancer among patients is expected to drive NET treatment market growth across the global.
Introduction The global embolic protection devices market size is anticipated to reach USD 2.0 billion by 2026, registering at a CAGR growth of 9.2% over the forecast period. Increasing cases of cardiovascular, neurovascular surgeries and also surge in huge investments in R&D of embolic devices are the main features driving the market development.
Introduction The global controlled release drug delivery market size is anticipated to around USD 91.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period. The market is driven by increasing technology spending in healthcare sector. Market Dynamics